节点文献
急性早幼粒细胞白血病的治疗演变
Therapeutic evolution of acute promyelocytic leukemia
【摘要】 急性早幼粒细胞白血病(acute promyelocytic leukemia,APL)是急性髓系白血病的一种特殊亚型,早期病死率较高。APL治疗经历了蒽环类药物为主的联合化疗、全反式维甲酸(all-trans retinotic acid,ATRA)、三氧化二砷(arsenictrioxide,ATO)等阶段,随着其治疗方案的优化,该病已成为可以治愈的疾病之一。
【Abstract】 Acute promyelocytic leukemia(APL) is a special subtype of acute myeloid leukemia with high early mortality.APL treatment has undergone anthracycline-based combination chemotherapy, all-trans retinoic acid, and arsenic trioxide. With the optimization of its treatment plan, the disease has become one of the curable diseases.
【基金】 吉林省科技发展计划项目(20170623092-TC-N012)~~
- 【文献出处】 临床与病理杂志 ,Journal of Clinical and Pathological Research , 编辑部邮箱 ,2019年05期
- 【分类号】R733.71
- 【被引频次】2
- 【下载频次】259